(Q38817840)

6 September 2017

Glucagon is the key factor in the development of diabetes (English)

1 reference

6 September 2017

1 reference

Young H Lee

1

1 reference

6 September 2017

May-Yun Wang

series ordinal

2

1 reference

6 September 2017

Xin-Xin Yu

series ordinal

3

1 reference

6 September 2017

Roger H Unger

series ordinal

4

1 reference

6 September 2017

26 April 2016

1 reference

6 September 2017

1 reference

6 September 2017

59

1 reference

6 September 2017

7

1 reference

6 September 2017

1372-1375

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-016-3965-9

6 September 2017

0 references

cites work

Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

The Banting Memorial Lecture 1975. Diabetes and the alpha cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Metabolic manifestations of insulin deficiency do not occur without glucagon action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

The Banting Memorial Lecture 1971. Physiology of insulin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Is HbA1c Affected by Glycemic Instability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Glucagon therapeutics, dawn of a new era for diabetes care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Leptin therapy in insulin-deficient type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Making insulin-deficient type 1 diabetic rodents thrive without insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-016-3965-9

Glucagon: Role in the Hyperglycemia of Diabetes Mellitus

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27115412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27115412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27115412

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-016-3965-9

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference